FATE

FATE THERAPEUTICS INCCIK 1434316 ☆ Sign in to watch Congress trades

Open-mkt buys · 90d

—

0 trades · 0 insiders

Open-mkt sales · 90d

—

0 trades · 0 insiders

Net · 90d

Insiders on file

AI insights for FATE PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

AI insights for FATE

Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.

Upgrade to Pro · $99/year Already Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

Insider	Role	Trades	Bought	Sold	Last trade
Valamehr Bahram	See Remarks	99	$0	$14.46M	2026-08-04
TAHL CINDY	See Remarks	139	$0	$28.83M	2026-08-04
Xu Yuan	Director	11	$0	$24.3K	2026-06-12
Jooss Karin	Director	12	$0	$33.8K	2026-06-12
Hamill Laura	Director	1	$0	$0	2026-06-12
Lee Michael Stewart	Director	11	$0	$0	2026-06-12
Agarwal Shefali	Director	13	$0	$36.8K	2026-06-12
ABERNETHY MATT	Director	2	$0	$0	2026-06-12
Redmile Group, LLC	Director, 10% Owner	16	$90.17M	$0	2026-06-12
EPSTEIN ROBERT S	Director	18	$0	$0	2026-06-12
RASTETTER WILLIAM H	Director	23	$1.50M	$0	2026-06-12
Green Jeremy	Director, 10% Owner	40	$67.53M	$2.34M	2026-04-20
Adawi Kamal	Chief Financial Officer	4	$0	$0	2026-01-15
Mozaffarian Neelufar	Director	2	$0	$0	2025-05-29
MENDLEIN JOHN	Director	24	$798.1K	$1.14M	2025-05-29
Bressi Jerome Charles	See Remarks	3	$0	$9.3K	2025-01-15
Coughlin Timothy P	Director	15	$150.0K	$32.8K	2024-06-07
Dulac Edward J III	Chief Financial Officer	30	$0	$2.88M	2024-03-04
Wolchko J Scott	See remarks	196	$0	$49.27M	2024-02-01
Powl Brian T.	Chief Commercial Officer	4	$0	$18.8K	2023-07-05
HERSHBERG ROBERT	Director	8	$0	$15.3K	2023-06-06
Chu Yu-Waye	Senior VP Clinical Development	22	$0	$1.05M	2023-04-18
Plavsic Mark	Chief Technical Officer	7	$0	$109.4K	2023-01-10
Shoemaker Daniel D	Chief Technology Officer	51	$0	$6.71M	2021-03-08
Nashat Amir	Director, 10% Owner	119	$5.00M	$22.96M	2019-08-01
ABBOT STEWART	Chief Development Officer	10	$0	$0	2018-05-15
Storgard Chris	Chief Medical Officer	5	$100.0K	$0	2018-01-16
Enyedy Mark J	Director	4	$0	$0	2017-05-02
Weyer Christian	See remarks	11	$0	$90.2K	2015-04-13
Flynn Peter D	See remarks	33	$0	$224.4K	2015-01-05
Multani Pratik S	Chief Medical Officer	3	$0	$0	2015-01-05
Venrock Management V, LLC	10% Owner	8	$5.00M	$0	2013-10-04
Polaris Venture Partners Special Founders' Fund V, L.P.	10% Owner	28	$5.00M	$0	2013-10-04
OVP VENTURE PARTNERS VII LP	10% Owner	12	$0	$0	2013-10-04
BYBEE CLINTON	10% Owner	7	$5.00M	$0	2013-10-04
NELSEN ROBERT	Director, 10% Owner	7	$5.00M	$0	2013-10-04

Trade history

Insider	Role	Code	Trade	Filed	Shares	Price	Value	Owned after
Valamehr Bahram	President and CEO	S Sale	2026-08-04	2026-08-05	43,947	$2.46	$108.1K	591,815	SEC↗
TAHL CINDY	See Remarks	S Sale	2026-08-04	2026-08-05	38,800	$2.46	$95.4K	589,355	SEC↗
TAHL CINDY	See Remarks	S Sale	2026-08-04	2026-08-05	38,800	$2.46	$95.4K	589,355	SEC↗
Valamehr Bahram	President and CEO, Director	S Sale	2026-08-04	2026-08-05	43,947	$2.46	$108.1K	591,815	SEC↗
Hamill Laura	Director	A Award deriv	2026-06-12	2026-06-15	175,800	—	$0	175,800	SEC↗
RASTETTER WILLIAM H	Director	A Award deriv	2026-06-12	2026-06-15	87,900	—	$0	87,900	SEC↗
ABERNETHY MATT	Director	A Award deriv	2026-06-12	2026-06-15	87,900	—	$0	87,900	SEC↗
Agarwal Shefali	Director	A Award deriv	2026-06-12	2026-06-15	87,900	—	$0	87,900	SEC↗
EPSTEIN ROBERT S	Director	A Award deriv	2026-06-12	2026-06-15	87,900	—	$0	87,900	SEC↗
Jooss Karin	Director	A Award deriv	2026-06-12	2026-06-15	87,900	—	$0	87,900	SEC↗
Xu Yuan	Director	A Award deriv	2026-06-12	2026-06-15	87,900	—	$0	87,900	SEC↗
Lee Michael Stewart	Director	A Award deriv	2026-06-12	2026-06-15	87,900	—	$0	87,900	SEC↗
Redmile Group, LLC	Director, 10% Owner	A Award deriv	2026-06-12	2026-06-15	87,900	—	$0	87,900	SEC↗
Valamehr Bahram	President and CEO	S Sale	2026-05-20	2026-05-21	28,946	$1.88	$54.4K	635,762	SEC↗
TAHL CINDY	See Remarks	S Sale	2026-05-20	2026-05-21	25,590	$1.88	$48.1K	628,155	SEC↗
TAHL CINDY	See Remarks	M Exercise deriv	2026-05-06	2026-05-07	44,444	—	$0	355,556	SEC↗
TAHL CINDY	See Remarks	M Exercise deriv	2026-05-06	2026-05-07	122,220	—	$0	152,780	SEC↗
TAHL CINDY	See Remarks	M Exercise	2026-05-06	2026-05-07	44,444	$1.05	$46.7K	653,745	SEC↗
TAHL CINDY	See Remarks	M Exercise	2026-05-06	2026-05-07	122,220	$1.32	$161.3K	609,301	SEC↗
RASTETTER WILLIAM H	Director	M Exercise deriv	2026-05-05	2026-05-06	25,000	—	$0	0	SEC↗
EPSTEIN ROBERT S	Director	M Exercise deriv	2026-05-05	2026-05-06	25,000	—	$0	0	SEC↗
RASTETTER WILLIAM H	Director	M Exercise	2026-05-05	2026-05-06	25,000	$1.69	$42.3K	36,331	SEC↗
EPSTEIN ROBERT S	Director	M Exercise	2026-05-05	2026-05-06	25,000	$1.69	$42.3K	36,331	SEC↗
Green Jeremy	Director, 10% Owner	J Other deriv	2026-04-20	2026-04-22	266,280	—	$0	0	SEC↗
Green Jeremy	Director, 10% Owner	J Other deriv	2026-04-20	2026-04-22	162,013	—	$0	0	SEC↗
Green Jeremy	Director, 10% Owner	J Other deriv	2026-04-20	2026-04-22	266,280	—	$0	502,769	SEC↗
Green Jeremy	Director, 10% Owner	J Other deriv	2026-04-20	2026-04-22	162,013	—	$0	2,755,086	SEC↗
Green Jeremy	Director, 10% Owner	J Other deriv	2026-04-20	2026-04-22	3,691,324	—	$0	3,893,674	SEC↗
Green Jeremy	Director, 10% Owner	J Other deriv	2026-04-20	2026-04-22	3,691,324	—	$0	0	SEC↗
Redmile Group, LLC	Director, 10% Owner	J Other deriv	2026-04-20	2026-04-23	266,280	—	$0	502,769	SEC↗
Redmile Group, LLC	Director, 10% Owner	J Other deriv	2026-04-20	2026-04-23	266,280	—	$0	0	SEC↗
Green Jeremy	Director, 10% Owner	J Other	2026-04-20	2026-04-22	8,977,624	—	$0	0	SEC↗
Green Jeremy	Director, 10% Owner	J Other	2026-04-20	2026-04-22	8,977,624	—	$0	12,884,277	SEC↗
Valamehr Bahram	President and CEO	A Award deriv	2026-01-15	2026-01-16	1,300,000	—	$0	1,300,000	SEC↗
Adawi Kamal	Chief Financial Officer	A Award deriv	2026-01-15	2026-01-16	75,000	—	$0	75,000	SEC↗
TAHL CINDY	See Remarks	A Award deriv	2026-01-15	2026-01-16	400,000	—	$0	400,000	SEC↗
Valamehr Bahram	President and CEO	A Award	2026-01-15	2026-01-16	335,000	—	$0	664,708	SEC↗
Adawi Kamal	Chief Financial Officer	A Award	2026-01-15	2026-01-16	25,000	—	$0	100,000	SEC↗
TAHL CINDY	See Remarks	A Award	2026-01-15	2026-01-16	100,000	—	$0	487,081	SEC↗
Valamehr Bahram	President and CEO	S Sale	2026-01-09	2026-01-12	5,190	$1.07	$5.6K	329,708	SEC↗
TAHL CINDY	See Remarks	S Sale	2026-01-09	2026-01-12	10,589	$1.06	$11.2K	387,081	SEC↗
Adawi Kamal	Chief Financial Officer	A Award deriv	2025-10-20	2025-10-21	375,000	—	$0	375,000	SEC↗
Adawi Kamal	Chief Financial Officer	A Award	2025-10-20	2025-10-21	75,000	—	$0	75,000	SEC↗
Valamehr Bahram	President and CEO	S Sale	2025-08-04	2025-08-05	14,466	$1.06	$15.3K	334,898	SEC↗
TAHL CINDY	See Remarks	S Sale	2025-08-04	2025-08-05	9,037	$1.06	$9.6K	397,670	SEC↗
Agarwal Shefali	Director	A Award deriv	2025-05-29	2025-05-30	55,000	—	$0	55,000	SEC↗
ABERNETHY MATT	Director	A Award deriv	2025-05-29	2025-05-30	110,000	—	$0	110,000	SEC↗
EPSTEIN ROBERT S	Director	A Award deriv	2025-05-29	2025-05-30	55,000	—	$0	55,000	SEC↗
Jooss Karin	Director	A Award deriv	2025-05-29	2025-05-30	55,000	—	$0	55,000	SEC↗
MENDLEIN JOHN	Director	A Award deriv	2025-05-29	2025-05-30	55,000	—	$0	55,000	SEC↗
RASTETTER WILLIAM H	Director	A Award deriv	2025-05-29	2025-05-30	55,000	—	$0	55,000	SEC↗
Mozaffarian Neelufar	Director	A Award deriv	2025-05-29	2025-05-30	55,000	—	$0	55,000	SEC↗
Xu Yuan	Director	A Award deriv	2025-05-29	2025-05-30	55,000	—	$0	55,000	SEC↗
Redmile Group, LLC	Director, 10% Owner	A Award deriv	2025-05-29	2025-05-30	55,000	—	$0	55,000	SEC↗
Lee Michael Stewart	Director	A Award deriv	2025-05-29	2025-05-30	55,000	—	$0	55,000	SEC↗
Valamehr Bahram	President and CEO	A Award deriv	2025-01-16	2025-01-16	1,300,000	—	$0	1,300,000	SEC↗
Bressi Jerome Charles	See Remarks	A Award deriv	2025-01-15	2025-01-16	250,000	—	$0	250,000	SEC↗
TAHL CINDY	See Remarks	A Award deriv	2025-01-15	2025-01-16	275,000	—	$0	275,000	SEC↗
Bressi Jerome Charles	See Remarks	A Award	2025-01-15	2025-01-16	65,000	—	$0	335,203	SEC↗
TAHL CINDY	See Remarks	A Award	2025-01-15	2025-01-16	70,000	—	$0	406,707	SEC↗
Valamehr Bahram	President and CEO	S Sale	2025-01-10	2025-01-13	8,705	$1.54	$13.4K	349,364	SEC↗
TAHL CINDY	See Remarks	S Sale	2025-01-10	2025-01-13	5,654	$1.55	$8.8K	336,707	SEC↗
Bressi Jerome Charles	See Remarks	S Sale	2025-01-10	2025-01-13	5,980	$1.55	$9.3K	270,203	SEC↗
Green Jeremy	Director, 10% Owner	J Other deriv	2024-12-20	2024-12-26	56,331	$1.68	$94.6K	502,769	SEC↗
Green Jeremy	Director, 10% Owner	J Other deriv	2024-12-20	2024-12-26	116,261	$8.40	$976.6K	2,755,086	SEC↗
Green Jeremy	Director, 10% Owner	J Other deriv	2024-12-20	2024-12-26	116,261	$8.40	$976.6K	2,638,825	SEC↗
Green Jeremy	Director, 10% Owner	P Buy	2024-12-20	2024-12-26	397,964	$1.68	$668.6K	12,884,277	SEC↗
Green Jeremy	Director, 10% Owner	J Other	2024-12-20	2024-12-26	1,084,936	$1.68	$1.82M	11,743,010	SEC↗
Green Jeremy	Director, 10% Owner	J Other	2024-12-20	2024-12-26	1,084,936	$1.68	$1.82M	12,827,946	SEC↗
Green Jeremy	Director, 10% Owner	S Sale	2024-12-20	2024-12-26	341,633	$1.68	$573.9K	12,486,313	SEC↗
Green Jeremy	Director, 10% Owner	C Conversion deriv	2024-12-12	2024-12-16	6,022	—	$0	2,755,086	SEC↗
Green Jeremy	Director, 10% Owner	C Conversion	2024-12-12	2024-12-16	30,110	—	$0	12,827,946	SEC↗
Xu Yuan	Director	S Sale	2024-08-06	2024-08-07	633	$4.23	$2.7K	8,669	SEC↗
Mozaffarian Neelufar	Director	A Award deriv	2024-07-29	2024-07-31	80,000	—	$0	80,000	SEC↗
TAHL CINDY	General Counsel and Secretar	A Award	2024-07-29	2024-07-31	200,000	—	$0	342,361	SEC↗
Valamehr Bahram	Chief R&D Officer	A Award	2024-07-29	2024-07-31	200,000	—	$0	358,069	SEC↗
MENDLEIN JOHN	Director	A Award deriv	2024-06-07	2024-06-11	40,000	—	$0	40,000	SEC↗
EPSTEIN ROBERT S	Director	A Award deriv	2024-06-07	2024-06-11	40,000	—	$0	40,000	SEC↗
Xu Yuan	Director	A Award deriv	2024-06-07	2024-06-11	40,000	—	$0	40,000	SEC↗
Agarwal Shefali	Director	A Award deriv	2024-06-07	2024-06-11	40,000	—	$0	40,000	SEC↗
COUGHLIN TIMOTHY	Director	A Award deriv	2024-06-07	2024-06-11	40,000	—	$0	40,000	SEC↗
Jooss Karin	Director	A Award deriv	2024-06-07	2024-06-11	40,000	—	$0	40,000	SEC↗
RASTETTER WILLIAM H	Director	A Award deriv	2024-06-07	2024-06-11	40,000	—	$0	40,000	SEC↗
Green Jeremy	Director, 10% Owner	A Award deriv	2024-06-07	2024-06-11	40,000	—	$0	40,000	SEC↗
Lee Michael Stewart	Director	A Award deriv	2024-06-07	2024-06-11	40,000	—	$0	40,000	SEC↗
Green Jeremy	Director, 10% Owner	A Award deriv	2024-03-21	2024-03-25	3,636,364	$5.50	$20.00M	3,893,674	SEC↗
Dulac Edward J III	Chief Financial Officer	S Sale	2024-03-04	2024-03-05	2,447	$7.77	$19.0K	101,479	SEC↗
Valamehr Bahram	Chief R&D Officer	A Award deriv	2024-02-01	2024-02-02	450,000	—	$0	450,000	SEC↗
Dulac Edward J III	Chief Financial Officer	A Award deriv	2024-02-01	2024-02-02	425,000	—	$0	425,000	SEC↗
TAHL CINDY	General Counsel and Secretar	A Award deriv	2024-02-01	2024-02-02	425,000	—	$0	425,000	SEC↗
Wolchko J Scott	President and CEO	A Award deriv	2024-02-01	2024-02-02	500,000	—	$0	500,000	SEC↗
Dulac Edward J III	Chief Financial Officer	S Sale	2024-01-29	2024-01-30	1,849	$5.00	$9.2K	103,926	SEC↗
Dulac Edward J III	Chief Financial Officer	S Sale	2024-01-09	2024-01-10	7,028	$4.37	$30.7K	105,775	SEC↗
Wolchko J Scott	President and CEO	S Sale	2024-01-09	2024-01-10	14,391	$4.37	$62.9K	371,248	SEC↗
Valamehr Bahram	Chief R&D Officer	S Sale	2024-01-09	2024-01-10	11,271	$4.38	$49.4K	158,069	SEC↗
TAHL CINDY	General Counsel and Secretar	S Sale	2024-01-09	2024-01-10	10,874	$4.37	$47.5K	142,361	SEC↗
Dulac Edward J III	Chief Financial Officer	S Sale	2024-01-02	2024-01-03	5,182	$3.66	$19.0K	112,803	SEC↗
Redmile Group, LLC	Director, 10% Owner	J Other	2023-12-26	2023-12-28	1,655,370	$3.72	$6.16M	13,135,758	SEC↗
Redmile Group, LLC	Director, 10% Owner	J Other	2023-12-26	2023-12-28	1,655,370	$3.72	$6.16M	13,135,758	SEC↗
Redmile Group, LLC	Director, 10% Owner	P Buy	2023-12-26	2023-12-28	44,630	$3.72	$166.0K	13,180,388	SEC↗
Dulac Edward J III	Chief Financial Officer	S Sale	2023-12-18	2023-12-19	1,585	$3.50	$5.5K	117,985	SEC↗
TAHL CINDY	General Counsel and Secretar	S Sale	2023-11-09	2023-11-13	24,363	$2.40	$58.5K	153,235	SEC↗
Dulac Edward J III	Chief Financial Officer	S Sale	2023-08-18	2023-08-21	4,718	$2.80	$13.2K	119,570	SEC↗
Xu Yuan	Director	S Sale	2023-08-04	2023-08-07	632	$3.71	$2.3K	9,302	SEC↗
Dulac Edward J III	Chief Financial Officer	S Sale	2023-07-05	2023-07-06	5,182	$4.83	$25.0K	124,288	SEC↗
Powl Brian T.	Chief Commercial Officer	S Sale	2023-07-05	2023-07-06	3,854	$4.87	$18.8K	41,146	SEC↗
Xu Yuan	Director	S Sale	2023-06-14	2023-06-15	3,460	$5.58	$19.3K	9,934	SEC↗
Agarwal Shefali	Director	A Award deriv	2023-06-06	2023-06-07	40,000	—	$0	40,000	SEC↗
COUGHLIN TIMOTHY	Director	A Award deriv	2023-06-06	2023-06-07	40,000	—	$0	40,000	SEC↗
EPSTEIN ROBERT S	Director	A Award deriv	2023-06-06	2023-06-07	40,000	—	$0	40,000	SEC↗
HERSHBERG ROBERT	Director	A Award deriv	2023-06-06	2023-06-07	40,000	—	$0	40,000	SEC↗
Jooss Karin	Director	A Award deriv	2023-06-06	2023-06-07	40,000	—	$0	40,000	SEC↗
MENDLEIN JOHN	Director	A Award deriv	2023-06-06	2023-06-07	40,000	—	$0	40,000	SEC↗
RASTETTER WILLIAM H	Director	A Award deriv	2023-06-06	2023-06-07	40,000	—	$0	40,000	SEC↗
Xu Yuan	Director	A Award deriv	2023-06-06	2023-06-07	40,000	—	$0	40,000	SEC↗
Lee Michael Stewart	Director	A Award deriv	2023-06-06	2023-06-08	40,000	—	$0	40,000	SEC↗
Green Jeremy	Director, 10% Owner	A Award deriv	2023-06-06	2023-06-08	40,000	—	$0	40,000	SEC↗
Green Jeremy	Director, 10% Owner	P Buy	2023-04-21	2023-04-21	256,639	$6.18	$1.59M	13,135,758	SEC↗
Green Jeremy	Director, 10% Owner	P Buy	2023-04-20	2023-04-21	20,000	$5.99	$119.8K	12,879,119	SEC↗
Chu Yu-Waye	Chief Medical Officer	S Sale	2023-04-18	2023-04-19	2,317	$6.58	$15.2K	140,676	SEC↗
Chu Yu-Waye	Chief Medical Officer	S Sale	2023-04-18	2023-04-19	215	$6.52	$1.4K	142,993	SEC↗
Green Jeremy	Director, 10% Owner	J Other deriv	2023-04-14	2023-04-17	550,000	$5.84	$3.21M	559,100	SEC↗
Green Jeremy	Director, 10% Owner	J Other deriv	2023-04-14	2023-04-17	45,752	$29.20	$1.34M	2,761,108	SEC↗
Green Jeremy	Director, 10% Owner	J Other deriv	2023-04-14	2023-04-17	45,752	$29.20	$1.34M	2,761,108	SEC↗
Green Jeremy	Director, 10% Owner	J Other deriv	2023-04-14	2023-04-17	54,960	$5.84	$321.0K	257,310	SEC↗
Green Jeremy	Director, 10% Owner	J Other deriv	2023-04-14	2023-04-17	54,960	$5.84	$321.0K	257,310	SEC↗
Green Jeremy	Director, 10% Owner	J Other deriv	2023-04-14	2023-04-17	550,000	$5.84	$3.21M	559,100	SEC↗
Green Jeremy	Director, 10% Owner	S Sale	2023-04-14	2023-04-17	302,339	$5.84	$1.77M	12,833,419	SEC↗
Green Jeremy	Director, 10% Owner	J Other	2023-04-14	2023-04-17	5,492,385	$5.84	$32.08M	12,833,419	SEC↗
Green Jeremy	Director, 10% Owner	P Buy	2023-04-14	2023-04-17	25,700	$6.00	$154.2K	12,859,119	SEC↗
Green Jeremy	Director, 10% Owner	J Other	2023-04-14	2023-04-17	5,492,385	$5.84	$32.08M	12,833,419	SEC↗
Green Jeremy	Director, 10% Owner	C Conversion deriv	2023-04-13	2023-04-17	33,441	—	$0	2,761,108	SEC↗
Green Jeremy	Director, 10% Owner	C Conversion	2023-04-13	2023-04-17	167,205	—	$0	13,135,758	SEC↗
Chu Yu-Waye	Chief Medical Officer	A Award deriv	2023-02-06	2023-02-07	425,000	—	$0	425,000	SEC↗
Dulac Edward J III	Chief Financial Officer	A Award deriv	2023-02-06	2023-02-07	425,000	—	$0	425,000	SEC↗
Powl Brian T.	Chief Commercial Officer	A Award deriv	2023-02-06	2023-02-07	425,000	—	$0	425,000	SEC↗
TAHL CINDY	General Counsel and Secretar	A Award deriv	2023-02-06	2023-02-07	425,000	—	$0	425,000	SEC↗
Valamehr Bahram	Chief R&D Officer	A Award deriv	2023-02-06	2023-02-07	450,000	—	$0	450,000	SEC↗
Wolchko J Scott	President and CEO	A Award deriv	2023-02-06	2023-02-07	500,000	—	$0	500,000	SEC↗
MENDLEIN JOHN	Director	M Exercise deriv	2023-01-19	2023-01-20	28,461	—	$0	0	SEC↗
MENDLEIN JOHN	Director	M Exercise	2023-01-19	2023-01-20	28,461	$1.37	$39.0K	311,231	SEC↗
MENDLEIN JOHN	Director	P Buy	2023-01-13	2023-01-13	36,631	$5.43	$198.9K	282,770	SEC↗
Valamehr Bahram	Chief R&D Officer	M Exercise deriv	2023-01-12	2023-01-13	423	—	$0	0	SEC↗
Valamehr Bahram	Chief R&D Officer	M Exercise	2023-01-12	2023-01-13	423	$1.37	$580	169,340	SEC↗
MENDLEIN JOHN	Director	P Buy	2023-01-11	2023-01-13	88,048	$5.67	$499.2K	246,139	SEC↗
Chu Yu-Waye	Chief Medical Officer	S Sale	2023-01-10	2023-01-11	7,825	$5.24	$41.0K	143,208	SEC↗
Dulac Edward J III	Chief Financial Officer	S Sale	2023-01-10	2023-01-11	7,331	$5.24	$38.4K	129,470	SEC↗
Plavsic Mark	Chief Technical Officer	S Sale	2023-01-10	2023-01-11	3,418	$5.24	$17.9K	123,705	SEC↗
TAHL CINDY	General Counsel and Secretar	S Sale	2023-01-10	2023-01-11	11,553	$5.24	$60.5K	177,598	SEC↗
Valamehr Bahram	Chief R&D Officer	S Sale	2023-01-10	2023-01-11	10,917	$5.24	$57.2K	168,917	SEC↗
Wolchko J Scott	President and CEO	S Sale	2023-01-10	2023-01-11	45,907	$5.24	$240.6K	385,639	SEC↗
Dulac Edward J III	Chief Financial Officer	S Sale	2022-08-18	2022-08-19	4,703	$29.75	$139.9K	137,233	SEC↗
Dulac Edward J III	Chief Financial Officer	S Sale	2022-08-18	2022-08-19	432	$30.41	$13.1K	136,801	SEC↗
Wolchko J Scott	President and CEO	M Exercise deriv	2022-07-22	2022-07-25	6,246	—	$0	0	SEC↗
Wolchko J Scott	President and CEO	M Exercise	2022-07-22	2022-07-25	6,246	$2.70	$16.9K	437,792	SEC↗
Wolchko J Scott	President and CEO	S Sale	2022-07-22	2022-07-25	2,923	$31.33	$91.6K	434,869	SEC↗
Wolchko J Scott	President and CEO	S Sale	2022-07-22	2022-07-25	620	$33.28	$20.6K	431,546	SEC↗
Wolchko J Scott	President and CEO	S Sale	2022-07-22	2022-07-25	2,703	$32.61	$88.1K	432,166	SEC↗
Wolchko J Scott	President and CEO	M Exercise deriv	2022-07-21	2022-07-25	30,000	—	$0	6,246	SEC↗
Wolchko J Scott	President and CEO	S Sale	2022-07-21	2022-07-25	10,829	$32.54	$352.4K	450,717	SEC↗
Wolchko J Scott	President and CEO	S Sale	2022-07-21	2022-07-25	19,171	$33.07	$634.0K	431,546	SEC↗
Wolchko J Scott	President and CEO	M Exercise	2022-07-21	2022-07-25	30,000	$2.70	$81.0K	461,546	SEC↗
Valamehr Bahram	Chief R&D Officer	M Exercise deriv	2022-07-07	2022-07-08	17,158	$2.73	$46.8K	13,156	SEC↗
Valamehr Bahram	Chief R&D Officer	M Exercise	2022-07-07	2022-07-08	17,158	$2.73	$46.8K	196,992	SEC↗
Valamehr Bahram	Chief R&D Officer	S Sale	2022-07-07	2022-07-08	17,158	$30.23	$518.7K	179,834	SEC↗
Valamehr Bahram	Chief R&D Officer	M Exercise deriv	2022-07-06	2022-07-07	2,000	$4.84	$9.7K	8,704	SEC↗
Valamehr Bahram	Chief R&D Officer	M Exercise deriv	2022-07-06	2022-07-07	5,842	$2.73	$15.9K	30,314	SEC↗
Valamehr Bahram	Chief R&D Officer	M Exercise	2022-07-06	2022-07-07	5,842	$2.73	$15.9K	187,676	SEC↗
Valamehr Bahram	Chief R&D Officer	M Exercise	2022-07-06	2022-07-07	2,000	$4.84	$9.7K	181,834	SEC↗
Valamehr Bahram	Chief R&D Officer	S Sale	2022-07-06	2022-07-07	7,842	$30.07	$235.8K	179,834	SEC↗
Plavsic Mark	Chief Technical Officer	S Sale	2022-07-05	2022-07-06	3,719	$24.61	$91.5K	127,123	SEC↗
Powl Brian T.	Chief Commercial Officer	A Award deriv	2022-06-27	2022-06-29	70,000	—	$0	70,000	SEC↗
Powl Brian T.	Chief Commercial Officer	A Award	2022-06-27	2022-06-29	45,000	—	$0	45,000	SEC↗
Agarwal Shefali	Director	A Award deriv	2022-06-09	2022-06-13	11,893	—	$0	11,893	SEC↗
COUGHLIN TIMOTHY	Director	A Award deriv	2022-06-09	2022-06-13	11,893	—	$0	11,893	SEC↗
EPSTEIN ROBERT S	Director	A Award deriv	2022-06-09	2022-06-13	11,893	—	$0	11,893	SEC↗
HERSHBERG ROBERT	Director	A Award deriv	2022-06-09	2022-06-13	11,893	—	$0	11,893	SEC↗
Jooss Karin	Director	A Award deriv	2022-06-09	2022-06-13	11,893	—	$0	11,893	SEC↗
MENDLEIN JOHN	Director	A Award deriv	2022-06-09	2022-06-13	11,893	—	$0	11,893	SEC↗
RASTETTER WILLIAM H	Director	A Award deriv	2022-06-09	2022-06-13	11,893	—	$0	11,893	SEC↗
Xu Yuan	Director	A Award deriv	2022-06-09	2022-06-13	11,893	—	$0	11,893	SEC↗
Lee Michael Stewart	Director	A Award deriv	2022-06-09	2022-06-13	11,893	—	$0	11,893	SEC↗
Redmile Group, LLC	Director, 10% Owner	A Award deriv	2022-06-09	2022-06-13	11,893	—	$0	11,893	SEC↗
Agarwal Shefali	Director	A Award	2022-06-09	2022-06-13	8,650	—	$0	10,490	SEC↗
COUGHLIN TIMOTHY	Director	A Award	2022-06-09	2022-06-13	8,650	—	$0	9,892	SEC↗
EPSTEIN ROBERT S	Director	A Award	2022-06-09	2022-06-13	8,650	—	$0	11,331	SEC↗
HERSHBERG ROBERT	Director	A Award	2022-06-09	2022-06-13	8,650	—	$0	10,659	SEC↗
Jooss Karin	Director	A Award	2022-06-09	2022-06-13	8,650	—	$0	9,848	SEC↗
MENDLEIN JOHN	Director	A Award	2022-06-09	2022-06-13	8,650	—	$0	166,741	SEC↗
RASTETTER WILLIAM H	Director	A Award	2022-06-09	2022-06-13	8,650	—	$0	11,331	SEC↗
Xu Yuan	Director	A Award	2022-06-09	2022-06-13	8,650	—	$0	13,394	SEC↗
Lee Michael Stewart	Director	A Award	2022-06-09	2022-06-13	8,650	—	$0	11,331	SEC↗
Redmile Group, LLC	Director, 10% Owner	A Award	2022-06-09	2022-06-13	8,650	—	$0	12,968,553	SEC↗
Agarwal Shefali	Director	S Sale	2022-06-07	2022-06-08	841	$21.89	$18.4K	1,840	SEC↗
Agarwal Shefali	Director	S Sale	2022-06-03	2022-06-06	807	$22.80	$18.4K	1,874	SEC↗
COUGHLIN TIMOTHY	Director	S Sale	2022-06-03	2022-06-06	1,439	$22.81	$32.8K	57,632	SEC↗
HERSHBERG ROBERT	Director	S Sale	2022-06-03	2022-06-06	672	$22.75	$15.3K	2,009	SEC↗
Jooss Karin	Director	S Sale	2022-06-03	2022-06-06	1,483	$22.82	$33.8K	1,198	SEC↗
MENDLEIN JOHN	Director	S Sale	2022-06-03	2022-06-06	1,364	$22.79	$31.1K	158,091	SEC↗
Agarwal Shefali	Director	S Sale	2022-06-03	2022-06-08	0	—	$0	2,681	SEC↗
TAHL CINDY	General Counsel and Secretar	M Exercise deriv	2022-06-01	2022-06-02	25,000	—	$0	54,210	SEC↗
TAHL CINDY	General Counsel and Secretar	M Exercise	2022-06-01	2022-06-02	25,000	$6.55	$163.8K	214,151	SEC↗
TAHL CINDY	General Counsel and Secretar	S Sale	2022-06-01	2022-06-02	25,000	$22.96	$574.0K	189,151	SEC↗
Wolchko J Scott	President and CEO	M Exercise deriv	2022-04-22	2022-04-25	10,000	$2.70	$27.0K	36,246	SEC↗
Wolchko J Scott	President and CEO	S Sale	2022-04-22	2022-04-25	9,162	$34.54	$316.5K	432,384	SEC↗
Wolchko J Scott	President and CEO	M Exercise	2022-04-22	2022-04-25	10,000	$2.70	$27.0K	441,546	SEC↗
Wolchko J Scott	President and CEO	S Sale	2022-04-22	2022-04-25	838	$35.15	$29.5K	431,546	SEC↗
Wolchko J Scott	President and CEO	M Exercise deriv	2022-04-21	2022-04-25	30,000	$2.70	$81.0K	46,246	SEC↗
Wolchko J Scott	President and CEO	S Sale	2022-04-21	2022-04-25	1,003	$37.90	$38.0K	431,546	SEC↗
Wolchko J Scott	President and CEO	S Sale	2022-04-21	2022-04-25	2,220	$36.70	$81.5K	432,549	SEC↗
Wolchko J Scott	President and CEO	S Sale	2022-04-21	2022-04-25	4,062	$35.73	$145.1K	434,769	SEC↗
Wolchko J Scott	President and CEO	M Exercise	2022-04-21	2022-04-25	30,000	$2.70	$81.0K	461,546	SEC↗
Wolchko J Scott	President and CEO	S Sale	2022-04-21	2022-04-25	22,715	$34.57	$785.3K	438,831	SEC↗
Chu Yu-Waye	Chief Medical Officer	S Sale	2022-04-19	2022-04-21	4,062	$35.37	$143.7K	151,033	SEC↗
TAHL CINDY	General Counsel and Secretar	M Exercise deriv	2022-04-01	2022-04-04	19,433	—	$0	8,195	SEC↗
TAHL CINDY	General Counsel and Secretar	M Exercise deriv	2022-04-01	2022-04-04	5,567	—	$0	79,210	SEC↗
TAHL CINDY	General Counsel and Secretar	S Sale	2022-04-01	2022-04-04	25,000	$38.85	$971.3K	189,151	SEC↗
TAHL CINDY	General Counsel and Secretar	M Exercise	2022-04-01	2022-04-04	5,567	$6.55	$36.5K	214,151	SEC↗
TAHL CINDY	General Counsel and Secretar	M Exercise	2022-04-01	2022-04-04	19,433	$4.84	$94.1K	208,584	SEC↗
Valamehr Bahram	Chief R&D Officer	M Exercise deriv	2022-03-14	2022-03-15	25,000	—	$0	36,156	SEC↗
Valamehr Bahram	Chief R&D Officer	S Sale	2022-03-14	2022-03-15	100	$34.04	$3.4K	179,834	SEC↗
Valamehr Bahram	Chief R&D Officer	S Sale	2022-03-14	2022-03-15	2,960	$33.30	$98.6K	179,934	SEC↗
Valamehr Bahram	Chief R&D Officer	S Sale	2022-03-14	2022-03-15	2,195	$32.49	$71.3K	182,894	SEC↗
Valamehr Bahram	Chief R&D Officer	S Sale	2022-03-14	2022-03-15	3,067	$31.66	$97.1K	185,089	SEC↗
Valamehr Bahram	Chief R&D Officer	S Sale	2022-03-14	2022-03-15	16,678	$30.36	$506.3K	188,156	SEC↗
Valamehr Bahram	Chief R&D Officer	M Exercise	2022-03-14	2022-03-15	25,000	$2.73	$68.3K	204,834	SEC↗
MENDLEIN JOHN	Director	M Exercise deriv	2022-03-10	2022-03-11	31,562	—	$0	0	SEC↗
MENDLEIN JOHN	Director	S Sale	2022-03-10	2022-03-11	19,493	$34.73	$677.0K	171,524	SEC↗
MENDLEIN JOHN	Director	S Sale	2022-03-10	2022-03-11	12,069	$35.48	$428.2K	159,455	SEC↗
MENDLEIN JOHN	Director	M Exercise	2022-03-10	2022-03-11	31,562	$1.63	$51.4K	191,017	SEC↗
TAHL CINDY	See Remarks	A Award deriv	2022-01-25	2022-01-27	53,058	—	$0	53,058	SEC↗
Wolchko J Scott	President and CEO	A Award deriv	2022-01-25	2022-01-27	289,403	—	$0	289,403	SEC↗
Dulac Edward J III	Chief Financial Officer	A Award deriv	2022-01-25	2022-01-27	53,058	—	$0	53,058	SEC↗
Plavsic Mark	Chief Technical Officer	A Award deriv	2022-01-25	2022-01-27	53,058	—	$0	53,058	SEC↗
Chu Yu-Waye	Chief Medical Officer	A Award deriv	2022-01-25	2022-01-27	53,058	—	$0	53,058	SEC↗
Valamehr Bahram	See Remarks	A Award deriv	2022-01-25	2022-01-27	53,058	—	$0	53,058	SEC↗
TAHL CINDY	See Remarks	A Award	2022-01-25	2022-01-27	33,302	—	$0	189,151	SEC↗
Dulac Edward J III	Chief Financial Officer	A Award	2022-01-25	2022-01-27	33,302	—	$0	141,936	SEC↗
Plavsic Mark	Chief Technical Officer	A Award	2022-01-25	2022-01-27	33,302	—	$0	130,842	SEC↗
Chu Yu-Waye	Chief Medical Officer	A Award	2022-01-25	2022-01-27	33,302	—	$0	155,095	SEC↗
Valamehr Bahram	See Remarks	A Award	2022-01-25	2022-01-27	33,302	—	$0	179,834	SEC↗
Wolchko J Scott	President and CEO	M Exercise deriv	2022-01-21	2022-01-24	10,000	$2.70	$27.0K	89,446	SEC↗
Wolchko J Scott	President and CEO	M Exercise deriv	2022-01-21	2022-02-04	10,000	—	$0	76,246	SEC↗
Wolchko J Scott	President and CEO	M Exercise	2022-01-21	2022-01-24	10,000	$2.70	$27.0K	441,546	SEC↗
Wolchko J Scott	President and CEO	S Sale	2022-01-21	2022-01-24	10,000	$38.02	$380.2K	431,546	SEC↗
Wolchko J Scott	President and CEO	M Exercise deriv	2022-01-20	2022-01-24	30,000	$2.73	$81.9K	20,000	SEC↗
Wolchko J Scott	President and CEO	M Exercise deriv	2022-01-20	2022-02-04	30,000	—	$0	86,246	SEC↗
Wolchko J Scott	President and CEO	M Exercise	2022-01-20	2022-01-24	30,000	$2.73	$81.9K	461,546	SEC↗
Wolchko J Scott	President and CEO	S Sale	2022-01-20	2022-01-24	30,000	$40.21	$1.21M	431,546	SEC↗
Wolchko J Scott	President and CEO	M Exercise	2022-01-20	2022-02-04	30,000	$2.70	$81.0K	461,546	SEC↗
Chu Yu-Waye	Senior VP Clinical Developme	S Sale	2022-01-11	2022-01-13	418	$49.10	$20.5K	121,793	SEC↗
Chu Yu-Waye	Senior VP Clinical Developme	S Sale	2022-01-11	2022-01-13	3,547	$48.44	$171.8K	122,211	SEC↗
Dulac Edward J III	Chief Financial Officer	S Sale	2022-01-11	2022-01-13	390	$49.16	$19.2K	108,634	SEC↗
Dulac Edward J III	Chief Financial Officer	S Sale	2022-01-11	2022-01-13	1,380	$48.25	$66.6K	109,024	SEC↗
Valamehr Bahram	Chief R&D Officer	S Sale	2022-01-11	2022-01-13	418	$49.12	$20.5K	146,532	SEC↗
Valamehr Bahram	Chief R&D Officer	S Sale	2022-01-11	2022-01-13	4,152	$48.44	$201.1K	146,950	SEC↗
TAHL CINDY	General Counsel and Secretar	S Sale	2022-01-11	2022-01-13	536	$49.15	$26.3K	155,849	SEC↗
TAHL CINDY	General Counsel and Secretar	S Sale	2022-01-11	2022-01-13	4,883	$48.46	$236.6K	156,385	SEC↗
Wolchko J Scott	President and CEO	S Sale	2022-01-11	2022-01-13	4,519	$49.07	$221.7K	431,546	SEC↗
Wolchko J Scott	President and CEO	S Sale	2022-01-11	2022-01-13	10,047	$48.50	$487.3K	436,065	SEC↗
Valamehr Bahram	Chief R&D Officer	S Sale	2022-01-10	2022-01-12	5,245	$46.33	$243.0K	151,453	SEC↗
Valamehr Bahram	Chief R&D Officer	S Sale	2022-01-10	2022-01-12	351	$47.17	$16.6K	151,102	SEC↗
TAHL CINDY	General Counsel and Secretar	S Sale	2022-01-10	2022-01-12	7,095	$46.37	$329.0K	161,911	SEC↗
TAHL CINDY	General Counsel and Secretar	S Sale	2022-01-10	2022-01-12	643	$47.15	$30.3K	161,268	SEC↗
Wolchko J Scott	President and CEO	S Sale	2022-01-10	2022-01-12	101	$47.72	$4.8K	446,112	SEC↗
Wolchko J Scott	President and CEO	S Sale	2022-01-10	2022-01-12	20,894	$47.17	$985.6K	446,213	SEC↗
Wolchko J Scott	President and CEO	S Sale	2022-01-10	2022-01-12	13,161	$46.36	$610.1K	467,107	SEC↗
TAHL CINDY	General Counsel and Secretar	M Exercise deriv	2022-01-03	2022-01-04	50,000	—	$0	66,643	SEC↗
TAHL CINDY	General Counsel and Secretar	S Sale	2022-01-03	2022-01-04	4,427	$57.76	$255.7K	214,579	SEC↗
TAHL CINDY	General Counsel and Secretar	M Exercise	2022-01-03	2022-01-04	50,000	$6.55	$327.5K	219,006	SEC↗
TAHL CINDY	General Counsel and Secretar	S Sale	2022-01-03	2022-01-04	27,812	$59.86	$1.66M	169,867	SEC↗
TAHL CINDY	General Counsel and Secretar	S Sale	2022-01-03	2022-01-04	861	$60.31	$51.9K	169,006	SEC↗
TAHL CINDY	General Counsel and Secretar	S Sale	2022-01-03	2022-01-04	16,900	$58.84	$994.4K	197,679	SEC↗
Dulac Edward J III	Chief Financial Officer	M Exercise deriv	2021-12-20	2021-12-21	14,437	—	$0	128,238	SEC↗
Dulac Edward J III	Chief Financial Officer	S Sale	2021-12-20	2021-12-21	15,977	$60.00	$958.6K	110,404	SEC↗
Dulac Edward J III	Chief Financial Officer	M Exercise	2021-12-20	2021-12-21	14,437	$35.52	$512.8K	126,381	SEC↗
Valamehr Bahram	Chief R&D Officer	M Exercise deriv	2021-12-13	2021-12-14	25,000	—	$0	61,156	SEC↗
Valamehr Bahram	Chief R&D Officer	S Sale	2021-12-13	2021-12-14	7,018	$46.72	$327.9K	172,580	SEC↗
Valamehr Bahram	Chief R&D Officer	S Sale	2021-12-13	2021-12-14	1,600	$49.27	$78.8K	156,698	SEC↗
Valamehr Bahram	Chief R&D Officer	M Exercise	2021-12-13	2021-12-14	25,000	$2.73	$68.3K	181,698	SEC↗
Valamehr Bahram	Chief R&D Officer	S Sale	2021-12-13	2021-12-14	6,564	$47.61	$312.5K	166,016	SEC↗
Valamehr Bahram	Chief R&D Officer	S Sale	2021-12-13	2021-12-14	7,718	$48.75	$376.3K	158,298	SEC↗
Valamehr Bahram	Chief R&D Officer	S Sale	2021-12-13	2021-12-14	2,100	$45.68	$95.9K	179,598	SEC↗
Chu Yu-Waye	Senior VP Clinical Developme	M Exercise deriv	2021-12-10	2021-12-13	7,500	—	$0	105,000	SEC↗
Chu Yu-Waye	Senior VP Clinical Developme	S Sale	2021-12-10	2021-12-13	900	$50.42	$45.4K	130,261	SEC↗
Chu Yu-Waye	Senior VP Clinical Developme	S Sale	2021-12-10	2021-12-13	2,097	$49.32	$103.4K	131,161	SEC↗
Chu Yu-Waye	Senior VP Clinical Developme	M Exercise	2021-12-10	2021-12-13	7,500	$16.32	$122.4K	133,258	SEC↗
Chu Yu-Waye	Senior VP Clinical Developme	S Sale	2021-12-10	2021-12-13	1,822	$52.37	$95.4K	127,394	SEC↗
Chu Yu-Waye	Senior VP Clinical Developme	S Sale	2021-12-10	2021-12-13	1,031	$53.66	$55.3K	126,363	SEC↗
Chu Yu-Waye	Senior VP Clinical Developme	S Sale	2021-12-10	2021-12-13	5	$55.54	$278	125,758	SEC↗
Chu Yu-Waye	Senior VP Clinical Developme	S Sale	2021-12-10	2021-12-13	600	$54.58	$32.7K	126,763	SEC↗
Chu Yu-Waye	Senior VP Clinical Developme	S Sale	2021-12-10	2021-12-13	1,045	$51.08	$53.4K	129,216	SEC↗
Chu Yu-Waye	Senior VP Clinical Developme	A Award	2021-11-19	2021-11-22	60,958	—	$0	125,758	SEC↗
Dulac Edward J III	Chief Financial Officer	A Award	2021-11-19	2021-11-22	59,540	—	$0	111,944	SEC↗
Plavsic Mark	Chief Technical Officer	A Award	2021-11-19	2021-11-22	59,540	—	$0	97,540	SEC↗
TAHL CINDY	General Counsel and Secretar	A Award	2021-11-19	2021-11-22	60,958	—	$0	169,006	SEC↗
Valamehr Bahram	Chief R&D Officer	A Award	2021-11-19	2021-11-22	60,958	—	$0	156,698	SEC↗
Wolchko J Scott	President and CEO	A Award	2021-11-19	2021-11-22	86,475	—	$0	480,268	SEC↗
Wolchko J Scott	President and CEO	M Exercise deriv	2021-11-18	2021-11-22	20,000	—	$0	79,446	SEC↗
Wolchko J Scott	President and CEO	M Exercise	2021-11-18	2021-11-22	20,000	$2.70	$54.0K	413,793	SEC↗